世界の輸血診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Blood Transfusion Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0912 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、輸血診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ELISA、NAT、ウエスタンブロットアッセイ、蛍光アッセイ、その他技術）、用途別市場規模（病院、クリニック、血液銀行、研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・輸血診断の市場動向 ・企業の競争状況、市場シェア ・輸血診断の種類別市場規模（ELISA、NAT、ウエスタンブロットアッセイ、蛍光アッセイ、その他技術） ・輸血診断の用途別市場規模（病院、クリニック、血液銀行、研究所、その他） ・輸血診断の北米市場規模2016-2027（アメリカ、カナダ） ・輸血診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・輸血診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・輸血診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・輸血診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Grifols、Thermo Fisher Scientific、Roche、bioMérieux、Bio-Rad、Ortho Clinical Diagnostics、Becton Dickinson、Fujirebio、DiaSorin (American Standard Companies)、Beckman Coulter、Diagast、Abbott、BAG Health Care、Quidel） ・結論

Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff.

Market Analysis and Insights: Global Blood Transfusion Diagnostics Market
The global Blood Transfusion Diagnostics market size is projected to reach US$ 4140 million by 2026, from US$ 2974.9 million in 2019, at a CAGR of 4.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Transfusion Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Transfusion Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Transfusion Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Transfusion Diagnostics market.

Global Blood Transfusion Diagnostics Scope and Market Size
Blood Transfusion Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Transfusion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology

Segment by Application
Hospitals
Clinics
Blood Banks
Laboratories
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Grifols
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Rad
Ortho Clinical Diagnostics
Becton Dickinson
Fujirebio
DiaSorin (American Standard Companies)
bioMérieux
Bio-Rad
Abbott

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Transfusion Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ELISA
1.2.3 NAT
1.2.4 Western Blot Assays
1.2.5 Fluorescence Assay
1.2.6 Other Technology
1.3 Market by Application
1.3.1 Global Blood Transfusion Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Blood Banks
1.3.5 Laboratories
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Blood Transfusion Diagnostics Market Perspective (2016-2027)
2.2 Blood Transfusion Diagnostics Growth Trends by Regions
2.2.1 Blood Transfusion Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Blood Transfusion Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Blood Transfusion Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Blood Transfusion Diagnostics Industry Dynamic
2.3.1 Blood Transfusion Diagnostics Market Trends
2.3.2 Blood Transfusion Diagnostics Market Drivers
2.3.3 Blood Transfusion Diagnostics Market Challenges
2.3.4 Blood Transfusion Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Blood Transfusion Diagnostics Players by Revenue
3.1.1 Global Top Blood Transfusion Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Blood Transfusion Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Blood Transfusion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Blood Transfusion Diagnostics Revenue
3.4 Global Blood Transfusion Diagnostics Market Concentration Ratio
3.4.1 Global Blood Transfusion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Transfusion Diagnostics Revenue in 2020
3.5 Blood Transfusion Diagnostics Key Players Head office and Area Served
3.6 Key Players Blood Transfusion Diagnostics Product Solution and Service
3.7 Date of Enter into Blood Transfusion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Transfusion Diagnostics Breakdown Data by Type
4.1 Global Blood Transfusion Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2022-2027)

5 Blood Transfusion Diagnostics Breakdown Data by Application
5.1 Global Blood Transfusion Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Blood Transfusion Diagnostics Market Size (2016-2027)
6.2 North America Blood Transfusion Diagnostics Market Size by Type
6.2.1 North America Blood Transfusion Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Blood Transfusion Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Blood Transfusion Diagnostics Market Size by Type (2016-2027)
6.3 North America Blood Transfusion Diagnostics Market Size by Application
6.3.1 North America Blood Transfusion Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Blood Transfusion Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Blood Transfusion Diagnostics Market Size by Application (2016-2027)
6.4 North America Blood Transfusion Diagnostics Market Size by Country
6.4.1 North America Blood Transfusion Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Blood Transfusion Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Blood Transfusion Diagnostics Market Size (2016-2027)
7.2 Europe Blood Transfusion Diagnostics Market Size by Type
7.2.1 Europe Blood Transfusion Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Blood Transfusion Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Blood Transfusion Diagnostics Market Size by Type (2016-2027)
7.3 Europe Blood Transfusion Diagnostics Market Size by Application
7.3.1 Europe Blood Transfusion Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Blood Transfusion Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Blood Transfusion Diagnostics Market Size by Application (2016-2027)
7.4 Europe Blood Transfusion Diagnostics Market Size by Country
7.4.1 Europe Blood Transfusion Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Blood Transfusion Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Blood Transfusion Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Blood Transfusion Diagnostics Market Size by Type
8.2.1 Asia-Pacific Blood Transfusion Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Blood Transfusion Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Blood Transfusion Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Blood Transfusion Diagnostics Market Size by Application
8.3.1 Asia-Pacific Blood Transfusion Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Blood Transfusion Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Blood Transfusion Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region
8.4.1 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Blood Transfusion Diagnostics Market Size (2016-2027)
9.2 Latin America Blood Transfusion Diagnostics Market Size by Type
9.2.1 Latin America Blood Transfusion Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Blood Transfusion Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Blood Transfusion Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Blood Transfusion Diagnostics Market Size by Application
9.3.1 Latin America Blood Transfusion Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Blood Transfusion Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Blood Transfusion Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Blood Transfusion Diagnostics Market Size by Country
9.4.1 Latin America Blood Transfusion Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Blood Transfusion Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Blood Transfusion Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Blood Transfusion Diagnostics Market Size by Type
10.2.1 Middle East & Africa Blood Transfusion Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Blood Transfusion Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Blood Transfusion Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Blood Transfusion Diagnostics Market Size by Application
10.3.1 Middle East & Africa Blood Transfusion Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Blood Transfusion Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Blood Transfusion Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country
10.4.1 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Blood Transfusion Diagnostics Introduction
11.1.4 Grifols Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.1.5 Grifols Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Blood Transfusion Diagnostics Introduction
11.3.4 Roche Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Blood Transfusion Diagnostics Introduction
11.4.4 bioMérieux Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.4.5 bioMérieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Blood Transfusion Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.5.5 Bio-Rad Recent Development
11.6 Ortho Clinical Diagnostics
11.6.1 Ortho Clinical Diagnostics Company Details
11.6.2 Ortho Clinical Diagnostics Business Overview
11.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Introduction
11.6.4 Ortho Clinical Diagnostics Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.6.5 Ortho Clinical Diagnostics Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Details
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Blood Transfusion Diagnostics Introduction
11.7.4 Becton Dickinson Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.7.5 Becton Dickinson Recent Development
11.8 Fujirebio
11.8.1 Fujirebio Company Details
11.8.2 Fujirebio Business Overview
11.8.3 Fujirebio Blood Transfusion Diagnostics Introduction
11.8.4 Fujirebio Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.8.5 Fujirebio Recent Development
11.9 DiaSorin (American Standard Companies)
11.9.1 DiaSorin (American Standard Companies) Company Details
11.9.2 DiaSorin (American Standard Companies) Business Overview
11.9.3 DiaSorin (American Standard Companies) Blood Transfusion Diagnostics Introduction
11.9.4 DiaSorin (American Standard Companies) Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.9.5 DiaSorin (American Standard Companies) Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Details
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter Blood Transfusion Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.10.5 Beckman Coulter Recent Development
11.11 Diagast
11.11.1 Diagast Company Details
11.11.2 Diagast Business Overview
11.11.3 Diagast Blood Transfusion Diagnostics Introduction
11.11.4 Diagast Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.11.5 Diagast Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Blood Transfusion Diagnostics Introduction
11.12.4 Abbott Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.12.5 Abbott Recent Development
11.13 BAG Health Care
11.13.1 BAG Health Care Company Details
11.13.2 BAG Health Care Business Overview
11.13.3 BAG Health Care Blood Transfusion Diagnostics Introduction
11.13.4 BAG Health Care Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.13.5 BAG Health Care Recent Development
11.14 Quidel
11.14.1 Quidel Company Details
11.14.2 Quidel Business Overview
11.14.3 Quidel Blood Transfusion Diagnostics Introduction
11.14.4 Quidel Revenue in Blood Transfusion Diagnostics Business (2016-2021)
11.14.5 Quidel Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Blood Transfusion Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ELISA
Table 3. Key Players of NAT
Table 4. Key Players of Western Blot Assays
Table 5. Key Players of Fluorescence Assay
Table 6. Key Players of Other Technology
Table 7. Global Blood Transfusion Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Blood Transfusion Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Blood Transfusion Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Blood Transfusion Diagnostics Market Share by Regions (2016-2021)
Table 11. Global Blood Transfusion Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Blood Transfusion Diagnostics Market Share by Regions (2022-2027)
Table 13. Blood Transfusion Diagnostics Market Trends
Table 14. Blood Transfusion Diagnostics Market Drivers
Table 15. Blood Transfusion Diagnostics Market Challenges
Table 16. Blood Transfusion Diagnostics Market Restraints
Table 17. Global Blood Transfusion Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Blood Transfusion Diagnostics Market Share by Players (2016-2021)
Table 19. Global Top Blood Transfusion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Transfusion Diagnostics as of 2020)
Table 20. Ranking of Global Top Blood Transfusion Diagnostics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Blood Transfusion Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Blood Transfusion Diagnostics Product Solution and Service
Table 24. Date of Enter into Blood Transfusion Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Blood Transfusion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Blood Transfusion Diagnostics Revenue Market Share by Type (2016-2021)
Table 28. Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Blood Transfusion Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Blood Transfusion Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Blood Transfusion Diagnostics Revenue Market Share by Application (2016-2021)
Table 32. Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Blood Transfusion Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Blood Transfusion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Blood Transfusion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Blood Transfusion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Blood Transfusion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Blood Transfusion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Blood Transfusion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Blood Transfusion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Blood Transfusion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Blood Transfusion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Blood Transfusion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Blood Transfusion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Blood Transfusion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Blood Transfusion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Blood Transfusion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Blood Transfusion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Blood Transfusion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Blood Transfusion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Blood Transfusion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Blood Transfusion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Blood Transfusion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Blood Transfusion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Blood Transfusion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Blood Transfusion Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Blood Transfusion Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Blood Transfusion Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Blood Transfusion Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Grifols Company Details
Table 65. Grifols Business Overview
Table 66. Grifols Blood Transfusion Diagnostics Product
Table 67. Grifols Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 68. Grifols Recent Development
Table 69. Thermo Fisher Scientific Company Details
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Blood Transfusion Diagnostics Product
Table 72. Thermo Fisher Scientific Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Blood Transfusion Diagnostics Product
Table 77. Roche Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 78. Roche Recent Development
Table 79. bioMérieux Company Details
Table 80. bioMérieux Business Overview
Table 81. bioMérieux Blood Transfusion Diagnostics Product
Table 82. bioMérieux Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 83. bioMérieux Recent Development
Table 84. Bio-Rad Company Details
Table 85. Bio-Rad Business Overview
Table 86. Bio-Rad Blood Transfusion Diagnostics Product
Table 87. Bio-Rad Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 88. Bio-Rad Recent Development
Table 89. Ortho Clinical Diagnostics Company Details
Table 90. Ortho Clinical Diagnostics Business Overview
Table 91. Ortho Clinical Diagnostics Blood Transfusion Diagnostics Product
Table 92. Ortho Clinical Diagnostics Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 93. Ortho Clinical Diagnostics Recent Development
Table 94. Becton Dickinson Company Details
Table 95. Becton Dickinson Business Overview
Table 96. Becton Dickinson Blood Transfusion Diagnostics Product
Table 97. Becton Dickinson Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 98. Becton Dickinson Recent Development
Table 99. Fujirebio Company Details
Table 100. Fujirebio Business Overview
Table 101. Fujirebio Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Fujirebio Recent Development
Table 103. DiaSorin (American Standard Companies) Company Details
Table 104. DiaSorin (American Standard Companies) Business Overview
Table 105. DiaSorin (American Standard Companies) Blood Transfusion Diagnostics Product
Table 106. DiaSorin (American Standard Companies) Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 107. DiaSorin (American Standard Companies) Recent Development
Table 108. Beckman Coulter Company Details
Table 109. Beckman Coulter Business Overview
Table 110. Beckman Coulter Blood Transfusion Diagnostics Product
Table 111. Beckman Coulter Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 112. Beckman Coulter Recent Development
Table 113. Diagast Company Details
Table 114. Diagast Business Overview
Table 115. Diagast Blood Transfusion Diagnostics Product
Table 116. Diagast Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 117. Diagast Recent Development
Table 118. Abbott Company Details
Table 119. Abbott Business Overview
Table 120. Abbott Blood Transfusion Diagnostics Product
Table 121. Abbott Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 122. Abbott Recent Development
Table 123. BAG Health Care Company Details
Table 124. BAG Health Care Business Overview
Table 125. BAG Health Care Blood Transfusion Diagnostics Product
Table 126. BAG Health Care Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 127. BAG Health Care Recent Development
Table 128. Quidel Company Details
Table 129. Quidel Business Overview
Table 130. Quidel Blood Transfusion Diagnostics Product
Table 131. Quidel Revenue in Blood Transfusion Diagnostics Business (2016-2021) & (US$ Million)
Table 132. Quidel Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Transfusion Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. ELISA Features
Figure 3. NAT Features
Figure 4. Western Blot Assays Features
Figure 5. Fluorescence Assay Features
Figure 6. Other Technology Features
Figure 7. Global Blood Transfusion Diagnostics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Blood Banks Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Other Case Studies
Figure 13. Blood Transfusion Diagnostics Report Years Considered
Figure 14. Global Blood Transfusion Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Blood Transfusion Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Blood Transfusion Diagnostics Market Share by Regions: 2020 VS 2027
Figure 17. Global Blood Transfusion Diagnostics Market Share by Regions (2022-2027)
Figure 18. Global Blood Transfusion Diagnostics Market Share by Players in 2020
Figure 19. Global Top Blood Transfusion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Transfusion Diagnostics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Blood Transfusion Diagnostics Revenue in 2020
Figure 21. Global Blood Transfusion Diagnostics Revenue Market Share by Type (2016-2021)
Figure 22. Global Blood Transfusion Diagnostics Revenue Market Share by Type (2022-2027)
Figure 23. North America Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Blood Transfusion Diagnostics Market Share by Type (2016-2027)
Figure 25. North America Blood Transfusion Diagnostics Market Share by Application (2016-2027)
Figure 26. North America Blood Transfusion Diagnostics Market Share by Country (2016-2027)
Figure 27. United States Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Blood Transfusion Diagnostics Market Share by Type (2016-2027)
Figure 31. Europe Blood Transfusion Diagnostics Market Share by Application (2016-2027)
Figure 32. Europe Blood Transfusion Diagnostics Market Share by Country (2016-2027)
Figure 33. Germany Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Blood Transfusion Diagnostics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Blood Transfusion Diagnostics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Blood Transfusion Diagnostics Market Share by Region (2016-2027)
Figure 43. China Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Blood Transfusion Diagnostics Market Share by Type (2016-2027)
Figure 51. Latin America Blood Transfusion Diagnostics Market Share by Application (2016-2027)
Figure 52. Latin America Blood Transfusion Diagnostics Market Share by Country (2016-2027)
Figure 53. Mexico Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Blood Transfusion Diagnostics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Blood Transfusion Diagnostics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Blood Transfusion Diagnostics Market Share by Country (2016-2027)
Figure 59. Turkey Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Blood Transfusion Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Grifols Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 65. bioMérieux Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 66. Bio-Rad Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 67. Ortho Clinical Diagnostics Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 68. Becton Dickinson Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 69. Fujirebio Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 70. DiaSorin (American Standard Companies) Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 71. Beckman Coulter Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 72. Diagast Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 73. Abbott Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 74. BAG Health Care Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 75. Quidel Revenue Growth Rate in Blood Transfusion Diagnostics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

---